Physician profile
Jan Ellen Berger
NPI 1023040367
$885,916.98
in general payments reported to CMS, 2019-2025
6 companies · $249K in 2025
The $249K reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $6,900 · 2021: $2,075 · 2022: $205K · 2023: $220K · 2024: $156K · 2025: $249K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $390K · Travel and Lodging: $227K · Food and Beverage: $7,693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $390,034.67 |
| Travel and Lodging | $227,090.63 |
| Food and Beverage | $7,692.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb Sa | $819,648.77 | 2022-2025 | |
| Genentech USA, INC. | $28,231.14 | 2019 | |
| Merck Sharp & Dohme LLC | $21,958.25 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $7,420.00 | 2023 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $6,225.00 | 2020-2021 | |
| Illumina, INC. | $2,433.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.